At BayTMS we recognize that each person is unique and requires treatment that is optimally suited for him or her. We are fortunate to have three different FDA-cleared devices, Brainsway, MagVita, & Neurostar TMS Therapy systems so that we can match the patient's clinical needs to the many different treatment approaches that we have available. Each of the devices has been proven to be clinically sound in treating Major Depressive Disorder and yet each has unique features.
Having this variety of TMS devices also allows us to treat other medical and mental health conditions such as:
Generalized Anxiety Disorder
Obsessive Compulsive Disorder
With the Brainsway, MagVita, & Neurostar TMS Therapy systems we are able to offer many therapeutic options for treating a broad range of clinical problems and to tailor the treatment to each individual's needs.
Brainsway: Deep TMS Therapy
Brainsway's TMS therapy is effective, safe and generally well-tolerated for patients with treatment-resistant depression. It is FDA cleared for patients who have tried several types of antidepressants without improvement. Brainsway Deep TMS Therapy does not generate systemic side effects, and does not require hospitalization or anesthesia.
Brainsway TMS therapy is based on a patent registered by the U.S. National Institutes of Health (NIH) and has been enthusiastically embraced by the international academic community and recognized by leading research institutions worldwide, with over 60 clinical studies performed.
MagVita TMS Therapy® System
The MagVita TMS Therapy® system is a complete system for effectively treating depression. It has been FDA cleared for "treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode" and CE approved for "treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from two prior antidepressant medications, at or above the minimal effective dose and duration in the current episode".
MagVita TMS was cleared in the EU in 2011 and has a proven track-record of treatment efficacy, usability, and quality.
Neurostar TMS Therapy® System
BayTMS has successfully treated many patients in Berkeley on the first TMS device cleared by the U.S. Food and Drug Administration (FDA) to treat patients with Major Depressive Disorder (MDD) who have not benefited from antidepressant treatment - NeuroStar TMS Therapy.
This breakthrough depression treatment uses a highly focused, pulsed magnetic field, similar in type and strength to those produced by a magnetic resonance imaging (MRI) machine, to stimulate function in brain regions known to affect mood.
Now I'm a NeuroStar TMS Commercial
Our Approach to TMS Therapy